Company news
Molecular Partners AG news in 2025
Molecular Partners AG's news releases, calls and decks from 2025, newest first.
Molecular Partners to Present at 44th Annual J.P. Morgan Healthcare Conference
December 18, 2025
Molecular Partners Forms Scientific Advisory Board to Accelerate Development of Targeted Radiotherapeutics
December 11, 2025
Molecular Partners Presents Updated Data from Ongoing Phase 1/2a Trial of MP0533 in AML at ASH Annual Meeting
December 7, 2025
Molecular Partners Presents New Data for DLL3 Targeting Radiotherapy MP0712 at TRP Summit Europe 2025, Highlighting Initial Human Images and Mechanism of Action
November 12, 2025
Molecular Partners to present updated data from Phase 1/2a trial of MP0533 in AML at ASH Annual Meeting
November 3, 2025
Molecular Partners presents additional preclinical proof-of-concept data on logic-gated CD3 Switch-DARPin at SITC 2025
November 3, 2025
Molecular Partners Reports Q3 2025 Financial Results and Clinical Progress, with DLL3-Targeting Radio-DARPin MP0712 Phase 1 Launch Expected in 2025
October 30, 2025
Molecular Partners reports financial results and highlights recent clinical pipeline progress for H1 2025
August 25, 2025
Molecular Partners appoints Martin Steegmaier as Chief Scientific Officer to drive discovery of next-gen DARPin therapeutics
August 21, 2025
Molecular Partners and Orano Med present preclinical data on mesothelin-targeting Radio-DARPin candidate MP0726 at SNMMI 2025
June 22, 2025
Molecular Partners presents positive data from ongoing Phase 1/2a trial of MP0533 in AML at EHA 2025
June 11, 2025
Molecular Partners Announces Planned Operational Efficiencies and Extension of Cash Runway
June 10, 2025
Molecular Partners to Present at Upcoming Investor Conferences
May 19, 2025
Molecular Partners Reports Financial Results and Highlights from Q1 2025
May 15, 2025
Molecular Partners presents new preclinical data on Radio-DARPin and Switch-DARPin programs at AACR 2025
April 25, 2025
Molecular Partners Announces all Board Proposals Approved at Annual General Meeting
April 16, 2025
Molecular Partners to hold three poster presentations at AACR 2025
March 25, 2025
Molecular Partners Publishes Invitation to Annual General Meeting 2025
March 25, 2025
Molecular Partners Reports Highlights from Q4 2024 and Key Financials for Full Year 2024
March 6, 2025
Molecular Partners Announces Participation at Upcoming Investor Conferences and 2024 Financial Results Conference Call
February 28, 2025
Decks in 2025
- SNMMI 2025
Conference · 12 slides · Jun 24, 2025